Do you counsel patients on lifelong topiramate to switch medications after they form a first symptomatic stone?

Topiramate remains a significant risk factor for recurrent stone formation. Yet, in many cases, it may be the only medication that controls the patient’s neurologic issues. Therefore, we will routinely have the patient perform two 24-hour urine collections and, more often than not, we will find hypo...